Hello, everybody, welcome back to psychedelics day. This is your host, Kyle Buller, and I'm joined with Michelle Janikian.

On today's episode, we are honored to have on

Dr. Robin Carrar Harris. Really grateful for Robin's time and for coming on the show. I feel

like it's been a long time coming, and it's definitely been on our guest list for a while.

So in today's episode, we talk about neuroscience, the Rebus model. We chat about psychiatry and just mental health and

maybe what the future looks like. And then also this really interesting concept, which I haven't

heard before. And so it was fun to chat about just this concept of maybe like the negative

aspects of neuroplasticity. We always talk about the positive

sides of neuroplasticity with psychedelics and mental health, but could there be, you know, any

negative aspects? And so I just bring up a concept around HPPD, you know, maybe seeing the world

in a new way and actually maybe having a hard time coming back from that. And then also learned a little bit about Robin's new position over at Neuroscape.

So that's the Neuroscape Psychedelics Division at the University of California, San Francisco.

So it sounds like Dr. Robin Carhart-Harris will be joining us here in the United States over in San Francisco.

I think he said in August. So

congratulations, Dr. Carr Harris on the new position. And yeah, we're excited to have you over here.

I think that's it for this intro. But before we jump into the episode, just want to say,

if you want to support us here at Psychedelics today,

be sure to follow us on the social media, Facebook, Instagram, Twitter. We actually do have

a TikTok. Don't really do too much on there, but trying to get a little bit better on there if

you're on there. And be sure to subscribe to our podcast wherever you listen to podcasts. And if you're feeling

called to it, leave a review on iTunes. That helps us out a whole bunch. And if you want to leave

a small monthly donation, you can do so at patreon.com slash psychedelics today. And one of the best

...